a public good project by the
Synthesis
Company
of California

© 2026

Vicente Vérez-Bencomo | doi.page

0 works0 citations0 h-index

Vicente Vérez-Bencomo

Finlay Institute(CU)

Publications by Year

Research Areas

Carbohydrate Chemistry and Synthesis, SARS-CoV-2 and COVID-19 Research, Glycosylation and Glycoproteins Research, Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines

Most-Cited Works

→ A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b(2004)484 cited
→ SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies(2021)88 cited
→ Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota(2020)81 cited
→ Effect of shape, size, and valency of multivalent mannosides on their binding properties to phytohemagglutinins(1998)74 cited
→ Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction(2019)69 cited
→ Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines(2021)66 cited

→ Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates(2018)

53 cited

→ Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial(2022)44 cited

→ Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection(2018)43 cited

→ Antigenicity and Immunogenicity of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b(2004)40 cited